Mechanism of modification of allograft antigenicity
Hullett, D.A.; Landry, A.S.; Sollinger, H.W.
Transplantation Proceedings 22(4): 1928-1929
1990
ISSN/ISBN: 0041-1345 PMID: 2389487 Document Number: 365300
Document emailed within 1 workday
Related Documents
Obochi, M.O.; Ratkay, L.G.; Levy, J.G. 1997: Prolonged skin allograft survival after photodynamic therapy associated with modification of donor skin antigenicity Transplantation 63(6): 810-817Uphoff, D.E. 1971: Modified antigenicity: an immunologic mechanism for species survival Transplantation Proceedings 3(1): 207-209
Moen, R.C.; Schears, G.J.; Hong, R. 1987: Modification of the sponge allograft model to study the immune response to bone marrow cells Bone Marrow Transplantation 1(4): 389-396
Lantz, O.; Alard, P.; Charpentier, B. 1993: Mechanism of allograft rejection Pathologie-Biologie 41(6): 515-520
Takada, H.; Kotani, S. 1986: The defense mechanism and its weakening: modification of the defense mechanism by microbes--increase of sensitivity to bacterial endotoxins by bacterial components Nihon Rinsho. Japanese Journal of Clinical Medicine 44(9): 1972-1980
Krams, S.M.; Egawa, H.; Quinn, M.B.; Martinez, O.M. 1995: Apoptosis as a mechanism of cell death in a rat model of liver allograft rejection Transplantation Proceedings 27(1): 466-467
Alekperov, U.K.; Abutalybov, M.G.; Bagirova, A.D. 1976: Mechanism of action of antimutagens. I. ionol modification of aberrations induced by different factors Genetika 12(7): 41-46
Zelck, U.; Karnstedt, U. 1993: The mechanism of action of selenium substitution in inflammatory diseases. Modification of the activity of antioxidative enzymes in patients with acute pancreatitis Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 48(2): 78-81
Cox, J.H.; Chisholm, P.M. 1987: Mechanism of action of cyclosporine in preventing cardiac allograft rejection. I. Rate of entry of lymphocytes from the blood, fibrin deposition, and expression of Ia antigens on infiltrating cells Transplantation 43(3): 338-342
Jordan, S.C.; Quartel, A.W.; Czer, L.S.; Admon, D.; Chen, G.; Fishbein, M.C.; Schwieger, J.; Steiner, R.W.; Davis, C.; Tyan, D.B. 1998: Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action Transplantation 66(6): 800-805
Kreis, H.A.; Ponticelli, C. 2001: Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors Transplantation 71(11 Suppl): Ss5-Ss9
Serón, D.; Moreso, F.; Ramón, J.M.; Hueso, M.; Condom, E.; Fulladosa, X.; Bover, J.; Gil-Vernet, S.; Castelao, A.M.; Alsina, J.; Grinyó, J.M. 2000: Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy Transplantation 69(9): 1849-1855
Barker, A.K.; McDaniel, D.Olga.; Zhou, X.; He, Z.; Aru, G.; Thomas, T.; Moore, C.K. 2010: Combined analysis of allograft inflammatory factor-1, interleukin-18, and Toll-like receptor expression and association with allograft rejection and coronary vasculopathy American Surgeon 76(8): 872-878
Nickel, P.; Lacha, J.; Ode-Hakim, S.; Sawitzki, B.; Babel, N.; Frei, U.; Volk, H.D.; Reinke, P. 2001: Cytotoxic effector molecule gene expression in acute renal allograft rejection: correlation with clinical outcome; histopathology and function of the allograft Transplantation 72(6): 1158-1160
Ketchum, R.J.; Moore, W.V.; Hegre, O.D. 1992: Increased islet allograft survival after extended culture by a mechanism other than depletion of donor APCs. Lack of correlation between the elimination of donor MHC class II-positive accessory cells and increased transplantability Transplantation 54(2): 347-351
Suiko, M.; Fernando, P.H.; Sakakibara, Y.; Nakajima, H.; Liu, M.C.; Abe, S.; Nakatsu, S. 1992: Post-translational modification of protein by tyrosine sulfation: active sulfate PAPS is the essential substrate for this modification Nucleic Acids Symposium Series 1992(27): 183-184
Zhang, Q-Wei.; Tomita, Y.; Matsuzaki, G.; Shimizu, I.; Iwai, T.; Okano, S.; Minagawa, R.; Nakashima, Y.; Sueishi, K.; Nomoto, K.; Yasui, H. 2002: Heart allograft tolerance without development of posttransplant cardiac allograft vasculopathy in chimerism-based, drug-induced tolerance Transplantation 73(4): 652-656
Tamura, K.; Jones, M.; Yamada, I.; Ferrans, V.J. 1995: Possibility for clinical use of mitral valve allograft: an experimental histopathological study in consideration with aortic valve allograft Kyobu Geka. Japanese Journal of Thoracic Surgery 48(13): 1088-1091
Lavrik, O.I.; Nevinskiĭ, G.A.; Riazankin, I.A. 1979: Influence of the structure of photoreactive ATP analogs on the affinity modification of phenylalanyl-tRNA synsthetase. Modification of the enzyme at two types of nucleotide sites Molekuliarnaia Biologiia 13(5): 1001-1011
Khananshvili, D.; Gromet-Elhanan, Z. 1982: Chemical modification of the beta-subunit isolated from a membrane-bound Fo-F1-ATP synthase: modification by 4-chloro-7-nitrobenzofurazan does not inhibit restoration of ATP synthesis or hydrolysis Biochemical and Biophysical Research Communications 108(2): 881-887